Page last updated: 2024-10-26

erythrosine and Osteoporosis, Postmenopausal

erythrosine has been researched along with Osteoporosis, Postmenopausal in 1 studies

Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.

Osteoporosis, Postmenopausal: Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanaka, M1
Ejiri, S1
Nakajima, M1
Kohno, S1
Ozawa, H1

Other Studies

1 other study available for erythrosine and Osteoporosis, Postmenopausal

ArticleYear
Changes of cancellous bone mass in rat mandibular condyle following ovariectomy.
    Bone, 1999, Volume: 25, Issue:3

    Topics: Animals; Bone Density; Bone Marrow; Cell Count; Estrogens; Female; Fluoresceins; Humans; Mandibular

1999